Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir

This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.

from Top Business News- News18.com https://ift.tt/3cb6mFS

• Tweet
• Share
• Share
• Share
• Share